Pablo Sanchez-Vela

7PUBLICATIONS
78CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Natural language processingMolecular targetsHaematological tumoursCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 18, 2025
Impact of Clonal Hematopoiesis on Solid Tumor Progression Following Radiation Therapy.

Jacqueline J Tao, Jeremy Setton, Pablo Sánchez Vela

|Nov 07, 2024
Automated real-world data integration improves cancer outcome prediction.

Justin Jee, Christopher Fong, Karl Pichotta

|Oct 17, 2024
Targetable treatment resistance in thyroid cancer with clonal hematopoiesis.

Vera Tiedje, Pablo Sánchez Vela, Julie L Yang

|Dec 26, 2023
High-risk and silent clonal hematopoietic genotypes in patients with nonhematologic cancer.

Aaron J Stonestrom, Kamal N Menghrajani, Sean M Devlin

|Aug 10, 2023
Associations Between Cancer Predisposition Mutations and Clonal Hematopoiesis in Patients With Solid Tumors.

Sebastià Franch-Expósito, Miika Mehine, Ryan N Ptashkin

|Aug 04, 2023
Blockade of IL-6 signaling alleviates atherosclerosis in Tet2-deficient clonal hematopoiesis.

Wenli Liu, Mustafa Yalcinkaya, Inés Fernández Maestre

Pageof 2